DI GIOVANNI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 4.965
EU - Europa 2.503
AS - Asia 2.194
SA - Sud America 308
AF - Africa 63
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.042
Nazione #
US - Stati Uniti d'America 4.918
SG - Singapore 767
CN - Cina 574
RU - Federazione Russa 503
UA - Ucraina 461
IT - Italia 393
HK - Hong Kong 270
DE - Germania 267
BR - Brasile 248
VN - Vietnam 206
FI - Finlandia 200
IE - Irlanda 175
JP - Giappone 142
PL - Polonia 132
GB - Regno Unito 124
FR - Francia 100
SE - Svezia 64
KR - Corea 45
IN - India 37
CI - Costa d'Avorio 32
AR - Argentina 25
BD - Bangladesh 24
MX - Messico 20
NL - Olanda 16
TR - Turchia 16
CA - Canada 14
IQ - Iraq 13
ID - Indonesia 12
MT - Malta 12
PH - Filippine 12
PK - Pakistan 12
BE - Belgio 11
RO - Romania 11
CO - Colombia 8
EC - Ecuador 8
PY - Paraguay 8
SA - Arabia Saudita 8
KE - Kenya 7
VE - Venezuela 7
CH - Svizzera 6
JO - Giordania 6
AT - Austria 5
AZ - Azerbaigian 5
ES - Italia 5
GE - Georgia 5
KZ - Kazakistan 5
MA - Marocco 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
AU - Australia 4
IR - Iran 4
KG - Kirghizistan 4
MY - Malesia 4
EU - Europa 3
HU - Ungheria 3
IL - Israele 3
LB - Libano 3
PA - Panama 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TN - Tunisia 3
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
EG - Egitto 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
LY - Libia 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.042
Città #
Ashburn 558
Singapore 529
Fairfield 461
Woodbridge 360
Chandler 306
Houston 306
San Jose 293
Hong Kong 264
Jacksonville 259
Ann Arbor 249
Wilmington 209
Seattle 186
Dublin 175
Cambridge 160
Tokyo 142
Zgierz 129
Frankfurt am Main 118
Santa Clara 114
Beijing 105
Medford 102
Moscow 89
Des Moines 75
Palermo 73
Nanjing 71
Princeton 66
Ho Chi Minh City 65
Lauterbourg 60
Tulsa 59
Hefei 52
Hanoi 50
New York 50
Boardman 48
Altamura 41
Buffalo 39
Dearborn 39
Los Angeles 39
San Diego 38
Lawrence 34
Abidjan 32
Council Bluffs 32
Dallas 29
Milan 28
Chicago 22
Shenyang 20
Changsha 19
Seongnam 19
São Paulo 19
Hebei 17
Haiphong 16
Jiaxing 15
Nanchang 14
Ludwigshafen am Rhein 13
Guangzhou 12
Rio de Janeiro 12
San Paolo di Civitate 12
Tianjin 12
Amsterdam 11
Brussels 11
Da Nang 11
Kumar 11
London 11
San Mateo 11
Atlanta 10
Helsinki 10
Jinan 10
Kunming 10
Auburn Hills 9
Columbus 9
Phoenix 9
Saint Petersburg 9
Shanghai 9
Cardiff 8
City of London 8
Hangzhou 8
Attard 7
Belo Horizonte 7
Brooklyn 7
Norwalk 7
Salt Lake City 7
Biên Hòa 6
Changchun 6
Nairobi 6
Zhengzhou 6
Amman 5
Boston 5
Brasília 5
Elk Grove Village 5
Hải Dương 5
Istanbul 5
Jeddah 5
Rome 5
Southend 5
Verona 5
Washington 5
Asunción 4
Baku 4
Bishkek 4
Bogotá 4
Buenos Aires 4
Bắc Giang 4
Totale 6.669
Nome #
Enhanced tonic GABAA inhibition in typical absence epilepsy 265
mGluR control of interneuron output regulates feedforward tonic GABAA inhibition in the visual thalamus 239
Central Serotonin2C Receptor: From Physiology to Pathology. 235
Effects of scopolamine on dopamine neurons in the substantia nigra: Role of the pedunculopontine tegmental nucleus. 234
Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: electrophysiological and neurochemical evidence in rats 233
7-Nitroindazole protects striatal neurons against MPP+ -induced degeneration. 232
Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis 222
Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study. 219
Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model? 218
A Diet for Dopaminergic Neurons? 214
Birth, life and death of dopaminergic neurons in the Substantia Nigra 212
Editorial [ Neurodegenerative Disorders: From Molecules to Man (Part 2) Guest Editors: Giuseppe Di Giovanni, Vincenzo Di Matteo and Ennio Esposito ] 205
Serotonin Involvement in the Basal Ganglia Pathophysiology: Could the 5-HT2C Receptor be a New Target for Therapeutic Strategies?. 193
ANTIOXIDANTS DIETERY INTAKE AND PARKINSON'S DISEASE 188
Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. 187
CCK-8S SYSTEMIC ADMINISTRATION BLOCKS THE 7-NITROINDAZOLE-INDUCED EFFECTS ON THE EEG OF STRIATUM AND GLOBUS PALLIDUS: A FFT ANALYSIS IN THE RAT 187
The Neurobiological Bases for the Pharmacotherapy of Nicotine Addiction. 184
Will it ever become possible to prevent dopaminergic neuronal degeneration? 183
THE SUBSTANTIA NIGRA DOPAMINERGIC NEURONS 172
Death in the substantia nigra: a motor tragedy. 171
Nitric Oxide Modulation Of The Basal Ganglia Circuitry: Therapeutic Implication For Parkinson's Disease And Other Motor Disorders 171
A. Chattopadhyah, Editor, Serotonin Receptors in Neurobiology, CRC Press, Taylor & Francis Group (2007) Price: £79.99, ISBN: 9780849339776. 170
Dopamine interaction with other neurotransmitter systems: Relevance in the pathophysiology and treatment of CNS disorders (editorial) 169
Neuroprotection in Parkinson's disease: a realistic goal? 168
Serotonin-dopamine interaction: electrophysiological evidence 164
Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies 162
Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: Implications for seizure susceptibility. 161
Role of serotonin in central dopamine dysfunction 160
Non-steroidal anti-inflammatory drugs in Parkinson’s disease 159
A rapid and quantitative technique to study striatal dopaminergic neurodegeneration by in vivo reverse microdialysis in rats 150
Selective Activation of Serotonin2C Receptors Stimulates GABA-ergic Function in the Rat Substantia Nigra Pars Reticulata: A Combined in Vivo Electrophysiological and Neurochemical Study. 147
Neurodegenerative disorders: from molecules to man (part 1) 147
INFLAMMATION IN PARKINSON'S DISEASE 144
ACETYLSALYCILIC ACID (ASA) PROTECTS AGAINST NEURONAL DAMAGE INDUCED BY 1-METHYL-4-PHENYLPYRIDINIUM IODIDE (MPP+) IN RAT STRIATUM: AN IN VIVO MICRODIALYSIS STUDY 142
CRUCIAL ROLE OF THE 5-HT2C RECEPTOR IN REGULATING THE ACTIVITY OF THE SUBSTANTIA NIGRA PARS RETICULATA NEURONS: AN ELECTROPHYSIOLOGICAL STUDY IN RATS 141
Cholinergic and monoaminergic modulation of tonic GABAA inhibition in the rat dorsal lateral geniculate nucleus 141
Involvement of Nitric Oxide in Nigrostriatal Dopaminergic System Degeneration : A Neurochemical Study. 140
Involvement of nitric oxide in the nigrostriatal dopaminergic system degeneration: a study on the 6-OHDA model of Parkinson's disease. 136
Electrophysiological and neurochemical characterization of 7-nitroindazole and molsidomine acute and sub-chronic administration effects in the dopaminergic nigrostriatal system in rats 135
Unilateral Nigral Lesion Induces Dramatic Bilateral Modification In Rat Brain Monoamine Levels: A Neurochemical Study. 134
Serotonin 5-HT2C Receptor and Dopamine Function in Depression 133
Serotonin and Dopamine Interaction: An Overview 132
T-patterns in the study of movement and behavioral disorders 132
Impact of Serotonin 2C Receptor Null Mutation on Physiology and Behavior Associated with Nigrostriatal Dopamine Pathway Function 129
Nitric oxide influences the activity of neurones in the subthalamic nucleus of the rat. 128
Serotonin Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinson’s Disease and Other Motor Disorders. 126
Role of nitric oxide on the conrol of the dopaminergic Nigrostriatal system: a combined electrophysiological And dialysis analysis in rats 125
Serotonin-Dopamine Interaction: Experimental and Therapeutic Evidence 122
Modifications induced on rat exploratory behavior by acoustic stimulation: a multivariate analysis 116
Extrasynaptic GABAA receptor gain-of-function in absence epilepsy: GHB and thip pharmacological models 114
The Pivotal Role of Nitric Oxide in 6-OHDA-induced Dopaminergic Neurotoxicity: Neurochemical Evidences in Rats 114
Role of nitric oxide in the controlo of maximal dentate gyrus activation by Lamotrigine in the rat 113
Microiontophoretic Evidence that Nitric Oxide Alters Spontaneous Activity of the Substantia Nigra Pars Reticulata Neurons in the Rat 111
ROLE OF CENTRAL 5-HT2C RECEPTOR IN THE CONTROLL OF BASAL GANGLIA FUNCTIONS 110
New Serotonin and Dopamine ligands for the treatment of neuropsychiatric disorders. 110
MUSCARINIC MODULATION OF THE ACTIVITY OF THE SUBSTANTIA NIGRA PARS COMPACTA NEURONS IN RATS: ROLE OF THE TEGMENTAL PEDUNCULOPONTINE NUCLEUS 108
Selective stimulation of serotonin2c receptors blocks the enhancement of striatal accumbal dopamine release by nicotine administration 104
Preferential modulation of the gabaergic vs. dopaminergic function in the substantia nigra by 5-TH2C receptor signaling: electrophysiological and neurochemical evidence 104
The Life Cycle of the Dopaminergic Neurons in the Substantia Nigra 103
SPECIAL ISSUE "NEURODEGENERATIVE DISORDERS: FROM MOLECULES TO MAN" 102
Electrophysiological and Neurochemical In Vivo Studies on Serotonin 5-HT 2C Control of Central Dopaminergic Function 100
ROLE OF CENTRAL 5-HT2C RECEPTOR IN THE CONTROLL OF BASAL GANGLIA FUNCTIONS. 100
THE BASAL GANGLIA PATHOPHYSIOLOGY: RECENT ADVANCES 97
New Serotonin and Dopamine ligands for the treatment of neuropsychiatric disorders.CURRENT TOPICS IN MEDICINAL CHEMISTRY, Volume 8, Number 12. 94
Nitric Oxide: Implications For The Etiology & Treatment Of Central Nervous System Disorders 91
Neurodegenerative Disorders: From Molecules to Man. Part II 83
Totale 10.135
Categoria #
all - tutte 34.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022629 24 167 3 9 39 13 24 24 89 56 26 155
2022/2023799 97 151 24 75 102 134 47 52 82 1 24 10
2023/2024336 11 73 21 40 21 87 25 23 0 1 5 29
2024/2025876 25 27 32 98 22 30 55 63 51 86 149 238
2025/20263.455 185 119 190 178 289 398 459 318 259 891 81 88
2026/202754 54 0 0 0 0 0 0 0 0 0 0 0
Totale 10.135